Previous Article | Next Article 
J Virol, August 1998, p. 6574-6580, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Apoptosis Induction by the Binding of the Carboxyl
Terminus of Human Immunodeficiency Virus Type 1 gp160 to
Calmodulin
Hiroki
Ishikawa,1
Masafumi
Sasaki,2
Satoshi
Noda,1 and
Yasuhiro
Koga1,*
Department of Infectious Diseases, Tokai
University School of Medicine, Isehara, Kanagawa
259-1193,1 and
Department of Virology,
Medical Institute of Bioregulation, Kyushu University, Fukuoka
812-8582,2 Japan
Received 18 November 1997/Accepted 25 April 1998
 |
ABSTRACT |
The role of calmodulin (CaM) in apoptosis induced by gp160 of human
immunodeficiency virus type 1 was investigated with cells undergoing
single-cell killing. These cells were found to express, under the
control of an inducible promoter, wild-type gp160 or mutant gp160
devoid of various lengths of the carboxyl terminus. Immunoprecipitation
accompanied by immunoblotting revealed binding of CaM to wild-type
gp160 but not to mutant gp160 bearing a carboxyl terminus with a
deletion spanning more than five amino acid residues. A significant
coenzyme activity was detected in the CaM bound to gp160 even in the
presence of a Ca2+ chelater, EGTA. The cells forming this
gp160-CaM complex exhibited an elevated intracellular Ca2+
level followed by DNA fragmentation, which is a hallmark of apoptosis, and finally cell killing, while the cells not forming this complex did
not show any significant elevation in Ca2+ level or DNA
fragmentation. These results thus indicated that CaM plays a key role
in gp160-induced apoptosis.
 |
INTRODUCTION |
Apoptosis is an active process of
cell death that serves diverse functions in multicellular organisms,
and under physiological conditions, it is tightly controlled. Recently,
many viruses have been found to induce apoptosis of infected cells, and
there is now mounting evidence that such virally induced apoptosis
contributes directly to the cytopathogenic effects of these viruses. On
the other hand, viruses also have their own antiapoptosis genes, which can block the premature death of infected cells to maximize the production of viral progeny (24). Therefore, an
investigation of the mechanism regulating apoptosis in virally
infected cells appears to be indispensable to elucidate the
pathophysiology of virally induced disease.
Human immunodeficiency virus (HIV) exerts an acute cytopathic effect on
single T cells in culture through a mechanism that is independent of
syncytium formation. Unlike syncytium formation, single-cell killing is
not susceptible to inhibition by soluble CD4 or neutralizing antibodies
(2). While the mechanism of single-cell killing by infection
with HIV needs further clarification, the event itself may play a
crucial role in determining whether cells acutely infected with HIV are
killed immediately or are latently infected and thus become reservoirs
for the virus. In previous studies (10, 11), we demonstrated
that the expression of gp160 of HIV in CD4+ cells causes
single-cell killing due to the formation of intracellular gp160
aggregates. In addition, apoptosis accompanied by intracellular Ca2+ elevation has also been shown to be the death
mechanism in this system (13, 22). Moreover, a calmodulin
(CaM) antagonist blocked the elevation of Ca2+ as well as
the following DNA fragmentation, thus suggesting that CaM-dependent
intracellular Ca2+ release by gp160 is one of the cardinal
events subsequently leading to apoptosis. In the present study, the
role of CaM in gp160-mediated apoptosis was investigated with cells
undergoing single-cell killing.
 |
MATERIALS AND METHODS |
Cell clones.
A gp160-expressing stable cell clone, UE160,
was made by the transfection of plasmid pSMTE7-160 into U937 cells, a
human CD4+ monocytoid cell line (13). pSMTE7-160
has a human metallothionein IIA gene as the promoter and is thus
inducible by the addition of heavy metal ions such as Cd2+.
862,
859,
855, and
821 were made by transfection into U937 cells of pSMTE7-160-
862 (encoding gp160 with the C-terminal 2 amino
acids deleted), -
859 (encoding gp160 with the C-terminal 5 amino
acids deleted), -
855 (encoding gp160 with the C-terminal 9 amino
acids deleted), and -
821 (encoding gp160 with the C-terminal 43 amino acids deleted), respectively. These mutant gp160-expressing plasmids were constructed by introducing a stop codon into the carboxyl-terminal region of env in pSMTE7-160 by the
oligonucleotide-directed mutagenesis method with mismatched 24-mer
synthetic DNA primers (21). One base located around the
center of these primers is replaced with another base to introduce a
stop codon in place of a sense codon, such that the primers for
pSMTE7-160-
862, -
859, -
855, and -
821 have the changes 8365 T to A, 8355 G to T, 8343 A to T, and 8242 T to A (BH10 numbering
[20]) in each 24-mer primer, respectively.
Immunoblotting and immunoprecipitation.
For the immunoblot
analysis, the cells were lysed in cold extraction buffer containing 20 mM Tris-HCl (pH 7.5), 0.15 M NaCl, 1% Nonidet P-40, 2 mM
phenylmethylsulfonyl fluoride, 10 µM aprotinin, 10 µM leupeptin,
and 10
6 M EGTA. A soluble cytoplasmic extract was
obtained after sonication and centrifugation at 10,000 × g for 30 min at 4°C. Proteins in the cytoplasmic extract
(100 µg for each lane) were separated by sodium dodecyl sulfate
(SDS)-7.5% polyacrylamide gel electrophoresis under reducing
conditions. The separated polypeptides were transferred to a
nitrocellulose sheet and treated with anti-envelope glycoprotein monoclonal antibody (MAb) 0.5
(mouse immunoglobulin G1 [IgG1]) (14) and peroxidase-linked second antibody, followed by
detection with an enhanced chemiluminescence system (Amersham, Little
Chalfont, United Kingdom) according to the manufacturer's
instructions. Densitometric analysis was performed with a
chromatoscanner. For immunoprecipitation, cell lysate containing 100 µg of protein was added with a saturating amount (2 µg) of anti-CaM
MAb (mouse IgG1) (catalog no. 05-173; Upstate Biotechnology Inc., Lake
Placid, N.Y.), incubated at 4°C for 16 h with rotation, and then
absorbed with 50 µl of protein G-coupled Sepharose (Pharmacia,
Upsala, Sweden) at 4°C for 2 h. These Sepharose beads were
washed five times with cold extraction buffer and heated at 95°C with
sample buffer containing 0.1 M Tris-HCl (pH 6.8), 2% SDS, 10%
2-mercaptoethanol, 20% glycerol, and 0.001% bromophenol blue to elute
absorbed materials. SDS-7.5% polyacrylamide gel electrophoresis was
then performed. The separated polypeptides were then analyzed by
immunoblotting with 0.5
as described above.
Measurement of intracellular Ca2+ level.
The
intracellular Ca2+ level was measured by using a confocal
laser microscope equipped with a digital image analyzer and fluorescent Ca2+ indicators, by a method described previously
(18). Briefly, cells at 106/ml were loaded with
10 µM
1-[2-amino-5-(2,7-dichloro-6-hydroxy - 3 - oxy - 9 - xanthenyl)phenoxy] - 2 - (2 - amino - 5 - methylphenoxy)ethane - N,N, N',N'-tetraacetic
acid, pentaacetoxymethyl ester (Fluo 3-AM; Dojindo Laboratory,
Kumamoto, Japan), and 0.1% p-3000 (Dojindo Laboratory) in a
Ca2+-staining buffer (137 mM NaCl, 2.7 mM KCl, 5 mM
glucose, 1 mg of bovine serum albumin per dl, 20 mM HEPES [pH 7.4]).
Samples were then washed, resuspended in the Ca2+-staining
buffer, transferred to a glass-bottom dish, and spun down. Then, the
intensity of fluorescence, reflecting the intracellular Ca2+ level, was analyzed with a confocal laser microscope.
As a positive control for Ca2+ flux, UE160 cells were
stimulated with A23187 (Sigma Chemical Co., St. Louis, Mo.) in
Ca2+-staining buffer containing 0.4 mM CaCl2.
Assay of the coenzyme activity of CaM.
The specific activity
of CaM as a coenzyme was assayed by determining the ability of CaM to
activate cyclic nucleotide phosphodiesterase (PDE) (EC 3. 1. 4. 17).
Cell lysates were prepared in the presence of 10
6 M EGTA
to prevent Ca2+-mediated activation of CaM from those cell
clones after induction. Envelope glycoprotein (Env)-CaM complex for one
sample was immunoprecipitated by addition of 2 µg of 0.5
to a cell
lysate containing 100 µg of protein and then absorbed to 50 µl of
protein G-coupled Sepharose beads as described above. Then, 2 µl of
Sepharose beads conjugated with Env-CaM complex was applied to a PDE
assay mixture consisting of a 1-ml final volume, according to a
previously described method (23). To make a calibration
curve between the amount of CaM and the PDE activity in the assay,
increasing amounts of highly purified CaM (product no. 1915; Sigma)
were added to the assay mixture with nontreated protein G-Sepharose
beads.
Determination of apoptosis in cell culture.
Cells of each
cell clone adjusted to 2 × 105/ml in RPMI 1640 medium
supplemented with 10% fetal calf serum were added with 10 µM
CdCl2 on day 0 and cultured thereafter. On each day, the number of viable cells was determined with a hemocytometer and 0.1%
trypan blue. Agonistic anti-Fas MAb CH-11 and neutralizing anti-Fas MAb
ZB4 were purchased from MBL, Nagoya, Japan, and added to the cell
culture on day 0 at concentrations of 25 and 250 ng/ml, respectively. A
cell cycle analysis to examine the degree of apoptosis was performed
after a 48-h culture by a method reported previously (16).
Briefly, the cells were fixed with 2% paraformaldehyde, permeabilized
with 0.1% Nonidet P-40, and treated with 0.05 mg of RNase A per ml for
30 min at 37°C. After being washed, the cells were stained with
propidium iodide. The cells in a discrete subpopulation of signals
under the G0/G1 cell cycle region (subdiploid cells) were thus designated cells undergoing apoptosis.
 |
RESULTS |
Complex formation between gp160 and CaM.
The cell clones were
examined for their levels of expression of Env by an immunoblot
analysis with an anti-Env MAb, 0.5
, after induction with 10 µM
CdCl2. At 4 h after induction, the expression levels
for gp160 and mutant gp160s reached their peaks, and the relative
expression levels as determined by densitometry were 1.0, 1.8, 1.9, 2.7, and 1.5 in UE160,
862,
859,
855, and
821 cells,
respectively (Fig. 1A). The UE160 cells
already contained a detectable amount of gp160 without induction,
whereas at 4 h after induction, the gp160 expression level was
more than five times higher, as reported in a previous paper
(13). Similar ratios for the Env expression levels among
these cell clones were also obtained from another immunoblot analysis
with a polyclonal anti-Env antibody (catalog no. 13-204-000; Advanced
Biotechnologies, Columbia, Md.) (data not shown). To determine whether
Env binds to CaM in these cell clones, lysate from each cell clone at
4 h postinduction was subjected to immunoprecipitation by an
anti-CaM MAb. Next, the precipitates were run on a polyacrylamide gel
and transferred to a nitrocellulose filter. The resulting blot was developed with the 0.5
MAb and second antibody, followed by
detection with an enhanced chemiluminescence system (Fig. 1B). While
coprecipitation of gp160 with CaM was detected in UE160 and
862
cells, no band corresponding to gp160 was found in
859,
855, or
821 cells by immunoprecipitation with anti-CaM antibody. In a
parallel experiment, almost equal amounts of CaM were found in the
lysates of UE160 and
862 cells, as well as
859,
855, and
821 cells, by an immunoblot analysis with anti-CaM MAb (Fig. 1C). To
exclude a nonspecific association of gp160 with contaminating proteins
during immunoprecipitation by the anti-CaM MAb, the lysates were
subjected to immunoprecipitation with MOL171, a mouse IgG1 MAb
recognizing the human Lck protein, which is irrelevant to Env
(17). As shown in Fig. 1D, MOL171 did not coprecipitate any
band corresponding to gp160, while the anti-CaM MAb specifically
coprecipitated this Env from UE160 cell lysate. Essentially the same
result was obtained in another series of experiments in which no EGTA
was added to the working solution (the data obtained in the presence of
EGTA is shown in Fig. 1). To further confirm such complex formation
between gp160 and CaM, the lysate from UE160 cells was first
immunoprecipitated with 0.5
, and then the precipitate was examined
with the anti-CaM MAb after gel electrophoresis (Fig. 1E). At 8 h
postinduction, a moderate but significant CaM band was able to be
coprecipitated with gp160 in UE160 cells but not at all in UE120 cells
expressing gp120. These results thus indicated that a complex between
gp160 and CaM is formed in the cells and that the C-terminal three to five amino acid residues of gp160 are crucial for such complex formation.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Immunoblot and immunoprecipitation analyses. For the
immunoblot analysis, the cell lysate from each cell clone, containing
100 µg of protein, was loaded as indicated at the top and then was
examined with an anti-Env MAb (A) or anti-CaM MAb (C). For the
detection of the gp160-CaM complex, the cell lysate was either (i)
immunoprecipitated with the anti-CaM MAb, electrophoresed on a
polyacrylamide gel, and then analyzed by immunoblotting with anti-Env
MAb (B) or (ii) subjected to the same procedure with the MAbs reversed
(E). The lysate was also subjected to immunoprecipitation with MOL171
or anti-CaM MAb and then analyzed by immunoblotting with 0.5 (D). As
the standard for gp160 in panel B, the lysate from UE160 cells
containing 100 µg of protein was loaded (lane S). As the standard for
CaM in panel E, 0.5 or 2.5 ng of a purified CaM was loaded. The
relative densities of bands corresponding to CaM as determined by
densitometry were 1.0, 4.4, 0.46, and 1.1 in the first four lanes,
respectively. The bands at around 49 kDa in panels B and D represent
mouse IgG.
|
|
Elevation of intracellular Ca2+ and induction of
apoptosis by the gp160-CaM complex.
In a previous study
(22), we found that an increase in intracellular
Ca2+ occurs postinduction before the appearance of DNA
fragmentation in UE160 cells. In addition, the Ca2+
increase was considered to play a key role in the occurrence of DNA
fragmentation, a hallmark of apoptosis, because chelation of such free
intracellular Ca2+ by treatment with
O,O'-bis(2-aminophenyl)ethyleneglycol-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) blocked the appearance of DNA
fragmentation after induction. Therefore, in the present study, the
intracellular Ca2+ concentration was measured by using a
fluorescent Ca2+ indicator (Fig.
2). As a positive control for
Ca2+ influx, UE160 cells were stimulated with A23187 at
0 s in the presence of 0.4 mM CaCl2 (Fig. 2a). The
Ca2+ influx in UE160 cells was maximal when 10 nM A23187
was added, and its level was more than 100 times higher than that found
in the UE160 cells after induction (Fig. 2b). The cell clones were then
examined for their Ca2+ level after induction in buffer
containing no CaCl2 (Fig. 2b).
859,
855,
821, and
UE120 cells, in which the Env expressed is unable to bind to CaM (Fig.
1), did not show any elevation in the intracellular Ca2+
level, whereas UE160 and
862 cells, in which the Env expressed is
capable of binding to CaM, demonstrated a significant increase of
Ca2+ at around 600 s after induction. Moreover, the
treatment of UE160 cells with 10 µM W7, a CaM antagonist, completely
blocked the elevation of Ca2+ after induction. These
results therefore suggested that the binding of gp160 to CaM and
subsequent activation of this coenzyme are prerequisites for the
elevation of the intracellular Ca2+ level. A
severalfold-higher level of Ca2+ in UE160 cells than in
U937 cells even at the initial level was thought to be due to leaky
expression of gp160 in the UE160 cells without induction, as shown in a
previous study (13). To substantiate the gp160-induced
activation of CaM, the specific activity of CaM as a coenzyme was
assayed by determining the ability of CaM to activate PDE, a
representative CaM-dependent enzyme that is transformed to an active
form by CaM in the presence of Ca2+. First, cell lysates
were prepared in the presence of 10
6 M EGTA to prevent
Ca2+-mediated activation of CaM from those cell clones
after induction. Second, the CaM bound to Env was immunoprecipitated
with 0.5
, and its coenzyme activity in the PDE assay system was
examined (Fig. 3). The Envs from UE160
and
862 cells, which are able to form a complex with CaM,
demonstrated a significant CaM coenzyme activity, while the Env from
859 cells, which is unable to form detectable complex with CaM,
showed only a minimal coenzyme activity. Moreover, in UE160 cells,
gp160 in the absence of W7 exhibited a three- to fivefold-higher
coenzyme activity at 10 and 240 min postinduction than did gp160 in the
presence of W7, while the amounts of CaM bound to gp160 were almost the
same as those for these two samples as shown in Fig. 1B. The coenzyme
activity of CaM thus appears to be enhanced by binding to gp160 even in
the absence of Ca2+. This event leads to the elevation of
the intracellular Ca2+ level through a CaM-mediated system.
This CaM-dependent elevation of the intracellular Ca2+
level was followed by DNA fragmentation and cell killing such that
UE160 and
862 cells, both of which demonstrated an elevation of
intracellular Ca2+, showed a high degree of DNA
fragmentation 48 h after induction (Fig.
4a) followed by extensive cell killing
(Fig. 5), while
859 cells, which have
only a minimal Ca2+ elevation, exhibited only marginal
increases in DNA fragmentation and cell killing. The inhibition of the
CaM-mediated elevation of Ca2+ by W7 (Fig. 2b) also blocked
the appearance of DNA fragmentation after induction, as shown in a
previous study (22). The binding of gp160 to CaM was thus
indicated to initiate a series of events, including Ca2+
elevation, which eventually lead the cells to apoptosis. The background
levels of apoptosis were somewhat higher in the
env-transfected cells than in control U937 cells (Fig. 4a).
It is thought that the leaky expression of Env in these transfected
cells induced this moderate level of apoptosis without induction. This
gp160-CaM-mediated apoptosis also appeared to take place independent of
Fas-mediated signal transduction, since a neutralizing anti-Fas MAb
could not prevent UE160 cells from undergoing apoptosis after induction (Fig. 4b).

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Time course of intracellular Ca2+ level. (a)
UE160 cells were treated with Fluo 3-AM, and the Ca2+
concentration over time was measured after the addition of various
amounts of A23187, as indicated at the top, at 0 s in the presence
of 0.4 mM CaCl2. (b) Each cell clone, as indicated at the
top of each panel, was treated with Fluo 3-AM, and the Ca2+
concentration over time was measured after the addition of 10 µM
CdCl2 at 0 s. In one case, W7 (10 µM) was added 5 min before the induction with CdCl2 (UE160+W7). Each curve
represents the mean of the fluorescence curves from 20 to 30 individual
cells.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 3.
CaM activity analyzed with the PDE assay system. Env-CaM
complex bound to Sepharose beads was obtained from the cell lysate of
each cell clone at 1, 10, and 240 min after induction with
CdCl2 as indicated on the left, and its CaM coenzyme
activity was examined by using the PDE assay system (23).
Where indicated, W7 was added to the cell culture 5 min before
induction. As a standard, 0, 1, 2, and 4 ng of purified CaM was added
to the PDE assay mixture with nontreated Sepharose beads. ND, not
determined. The bars represent the standard errors (n = 3).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Detection of apoptosis by cell cycle analysis. (a) The
proportion of cells undergoing apoptosis was examined by cell cycle
analysis with each cell clone, as indicated to the right, at 0 and
48 h after induction. The numbers indicate the percentages of
subdiploid cells and the percentages of apoptotic cells. (b) UE160
cells were treated with CH-11 (A) or CH-11 plus ZB-4 (B) for 24 h
in the absence of induction. In addition, UE160 cells were cultured
either without (C) or with (D) the addition of CdCl2 as an
inducer for 48 h. (E and F) Same experiments as in panels C and D,
respectively, except in the presence of ZB-4. The numbers represent the
percentages of subdiploid cells.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 5.
Cell growth after induction. Each cell clone, as
indicated at the top of each panel, was adjusted to 5 × 105 cells in 10 ml of RPMI 1640 medium on day 0 and
cultured either with (closed circles) or without (open circles) 10 µM
CdCl2. On each day, 1 ml of cell suspension was removed
from the cultures, and the number of viable cells in the cell
suspension was measured.
|
|
Dissociation of surface CD4 downregulation from apoptosis
induction.
In our previous study (11), we showed that
the intracellular expression of gp160 in CD4+ cells
preceded the downregulation of surface CD4 and single-cell killing. An
analysis of these cells demonstrated that the intracellular sequestration of CD4 by gp160 causes such downregulation of surface CD4. This finding also suggested the possible participation of such a
gp160-CD4 complex in single-cell killing accompanied by the CD4
downregulation. In the present study, however, in view of the
downregulation of surface CD4 after induction, it appears unlikely that
such complex formation between gp160 and CD4 is directly involved in
cell killing due to apoptosis, because not only UE160 cells but also
859 cells, which do not succumb to apoptosis after induction,
exhibited a complete downregulation of surface CD4 after induction
(Fig. 6). The possibility that such
downregulation is an artifact of CdCl2 treatment was
eliminated in a previous study (10).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Fluorescence-activated cell sorter analysis of surface
CD4. UE160 or 859 cells were cultured for 4 h either without
( ) or with (+) the addition of 10 µM CdCl2. The cells
were then examined for their levels of expression of surface CD4 with a
FACScan with MAb Leu3a (anti-CD4; Becton Dickinson, San Jose, Calif.),
OKT4 (anti-CD4; Ortho Diagnostic Inc., Raritan, N.J.), or NU-Lpan
(anti-CD45; Nichirei Corp., Tokyo, Japan) as indicated on the right.
The amounts of these MAbs which bound to the cell surface were then
revealed by secondary staining with fluorescein
isothiocyanate-anti-mouse IgG antibody (Tago Inc., Burlingame,
Calif.). Cells treated only with fluorescein isothiocyanate-anti-mouse
IgG antibody were used as an autofluorescence control (C).
|
|
 |
DISCUSSION |
Fisher et al. (7) reported a variant of HIV type 1 (HIV-1) that replicates well but does not kill normal human T cells in
vitro. This variant, designated X10-1, was derived from the genome of a
cytopathic human T-cell leukemia virus type 3 clone (pXHB2D) by
excising the portion of the envelope gene encoding the C-terminal five
amino acid residues. As a result, the possibility was raised that the
carboxyl terminus of the envelope protein of HIV-1 plays a direct role
in T-cell killing by this virus. The env gene of pXH2BD is
essentially identical to that used in our present study. This means
that UE160 cells express the Env protein of cytopathic wild-type HIV-1,
while
859 cells express that of noncytopathic X10-1 HIV-1. Taken
together, the results of the present study supported the hypothesis of
Fisher et al. (7) that the carboxyl terminus of Env plays a
key role in Env-mediated cell killing of HIV infection, and they also
indicate that the binding of CaM to the carboxyl terminus and
subsequent apoptosis induction therefore constitute the causal
mechanism of such cell killing in those cells infected with HIV-1.
CaM is a multifunctional Ca2+-binding protein that is
ubiquitous in eukaryotes. It has no intrinsic enzyme activity, but it mediates the control of a wide spectrum of enzymes by Ca2+
(9). Amphipathic helical segments have been identified as an
important structural motif in the recognition of CaM by different CaM-activated enzymes (5). The carboxyl-terminal domains of the Envs of HIV and simian immunodeficiency viruses contain regions that can fold into amphipathic helical segments, which closely resemble
the amphipathic segments found in CaM-activated enzymes. Srinivas et
al. (25) showed by a gel overlay assay that purified HIV-1
gp160 binds to CaM in either the presence or absence of Ca2+, although binding was greatly diminished in the
absence of Ca2+. In contrast, gp120, which lacks putative
amphipathic helical segments, did not bind to CaM. In line with their
findings, the present in vivo study also demonstrated the binding of
gp160 to CaM in the cells by its carboxyl terminus. Miller et al.
(15) reported that a synthetic peptide homolog encompassing
27 amino acid residues of the carboxyl terminus is critical for
gp160-CaM interaction, since this peptide binds efficiently to purified CaM and inhibits the CaM-mediated stimulation of phosphodiesterase activity in vitro. The present study, on the other hand, revealed that
only a segment spanning three to five amino acid residues of the
carboxyl terminus is crucial for gp160 to bind to CaM and activate CaM
in the cells. Such CaM-bound gp160 exerted a significant level of
coenzyme activity even in the presence of EGTA, thus suggesting that
the gp160-mediated activation of CaM can occur either in the absence
Ca2+ of at a very low Ca2+ concentration.
The elevation of Ca2+ by the expression of Envs was
abrogated by deleting the CaM-binding domain from them or in the
presence of a CaM antagonist. Nicotera et al. (19) reported
that the incubation of isolated rat liver nuclei with ATP and
Ca2+ led to the uptake of Ca2+ into the nuclei.
Such an accumulation of Ca2+ in the nuclei was attributed
to the activity of the Ca2+ pump located in the nuclear
envelope, and activation of CaM was required for the start of this
Ca2+ pump. This finding raises the possibility that a
CaM-dependent Ca2+ pump is also responsible for the
elevation of Ca2+ in gp160-expressing cells, while
Ca2+ elevation in these cells seems to be confined to the
nuclear region, as reported previously (22); however, this
cannot yet be definitely concluded.
The biochemical hallmark of apoptosis is the cleavage of chromatin into
nucleosomal fragments. It appears likely that Ca2+
signaling is a critical event leading to such DNA fragmentation by
gp160, because the blocking of Ca2+ elevation by BAPTA-AM
or W7 also inhibited the appearance of fragmented DNA in UE160 cells,
as reported in a previous study (22). However, it remains
unclear how Ca2+ signaling leads to apoptosis events,
including DNA fragmentation. Multiple lines of evidence indicate that
apoptosis can be triggered by the activation of a family of cysteine
proteases designated caspases. Recently, Liu et al. (12)
identified a 45-kDa heterodimer protein, designated DNA fragmentation
factor (DFF), which functions downstream of caspase-3 to trigger DNA
fragmentation during apoptosis. DFF itself showed no DNase activity,
and it is therefore likely that DFF activates a nuclease(s) that
resides in the nuclei. One candidate is a
Ca2+/Mg2+-dependent nuclease which has been
described previously (8), and Ca2+ signaling
evoked by gp160-CaM interaction may participate in this stage of the
apoptosis pathway.
Cao et al. (3) reported that the expression of Env from
HIV-1 in T-cell lines resulted in single-cell lysis, as shown in our
present study with a monocytoid cell line, U937. In their system,
however, the single-cell lysis involved primarily necrosis, possibly
mediated by Env. Moreover, the cytoplasmic tail of the gp41
transmembrane Env, which is the crucial part for induction of
CaM-mediated cell killing, was neither necessary nor sufficient for
single-cell lysis. In this study, on the other hand, we aimed to
elucidate the role of gp160-CaM interaction in the single-cell killing
by using U937 cells, which have CD4 but not CD4 bound to Lck, a
tyrosine kinase predominant in T cells (17). Lck is reported
to play an important role in HIV-induced cell killing by binding to CD4
and acting as an adapter to anchor other proteins to transduce the
death signal (4). Such an Lck-mediated death pathway is thus
suggested to prevail over the CaM-mediated death signal in the system
used by Cao et al. (3), with T-cell lines.
Monocytes and macrophages can be infected with HIV; however, HIV does
not induce a significant cytopathic effect in these cells
(6). We used U937 cells as the target cells for transfection of env plasmids in the present study because this vector
expresses Env very efficiently in this cell line. The U937 cell line
used in this study is a subclone derived from the parental U937 cell clone, a human monocytoid tumor cell line, and is named U937 clone 2, as previously reported (11). This subclone has cytological properties different from those of the U937 parental clone, such as
higher levels of surface CD4 expression and activities of several intracellular enzymes (1). This change in cytological
properties may thus make U937 clone 2 susceptible to the cytopathic
effects of Env, whereas this cell line is originally derived from human monocytes that are resistant to such cytopathic effects.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Infectious Diseases, Tokai University School of Medicine, Isehara,
Kanagawa 259-1193, Japan. Phone: 463-93-1121, ext. 2591. Fax:
463-94-2976.
 |
REFERENCES |
| 1.
|
Asjo, B.,
I. Ivhed,
M. Gidlund,
S. Fuerstenberg,
E. M. Fenyo,
K. Nilsson, and H. Wigzell.
1987.
Susceptibility to infection by the human immunodeficiency virus correlates with T4 expression in a parental monocytoid cell line and its subclones.
Virology
157:359-365[Medline].
|
| 2.
|
Bergeron, L., and J. Sodroski.
1992.
Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.
J. Virol.
66:5777-5787[Abstract/Free Full Text].
|
| 3.
|
Cao, J.,
I.-W. Park,
A. Cooper, and J. Sodroski.
1996.
Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.
J. Virol.
70:1340-1354[Abstract].
|
| 4.
|
Corbeil, J.,
M. Tremblay, and D. D. Richman.
1996.
HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck.
J. Exp. Med.
183:39-48[Abstract/Free Full Text].
|
| 5.
|
Cox, J. A.,
M. Comte,
J. E. Fitton, and W. F. Degrado.
1985.
The interaction of calmodulin with amphiphilic peptides.
J. Biol. Chem.
260:2527-2534[Abstract/Free Full Text].
|
| 6.
|
Fauci, A. S.
1988.
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
Science
239:617-622[Abstract/Free Full Text].
|
| 7.
|
Fisher, A. G.,
L. Ratner,
H. Mitsuya,
L. M. Marselle,
M. E. Harper,
S. Broder,
R. C. Gallo, and F. Wong-Staal.
1986.
Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects.
Science
233:655-659[Abstract/Free Full Text].
|
| 8.
|
Gaido, M. L., and J. A. Cidlowski.
1991.
Identification, purification, and characterization of a calcium-dependent endonuclease (NUC18) from apoptotic rat thymocytes.
J. Biol. Chem.
266:18580-18585[Abstract/Free Full Text].
|
| 9.
|
Klee, C. B.,
T. H. Crouch, and P. G. Richman.
1980.
Calmodulin.
Annu. Rev. Biochem.
49:489-515[Medline].
|
| 10.
|
Koga, Y.,
K. Nakamura,
M. Sasaki,
G. Kimura, and K. Nomoto.
1994.
The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing.
Virology
201:137-141[Medline].
|
| 11.
|
Koga, Y.,
M. Sasaki,
H. Yoshida,
H. Wigzell,
G. Kimura, and K. Nomoto.
1990.
Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV-1.
J. Immunol.
144:94-102[Abstract].
|
| 12.
|
Liu, X.,
H. Zou,
C. Slaughter, and X. Wang.
1997.
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.
Cell
89:175-184[Medline].
|
| 13.
|
Lu, Y.-Y.,
Y. Koga,
K. Tanaka,
M. Sasaki,
G. Kimura, and K. Nomoto.
1994.
Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.
J. Virol.
68:390-399[Abstract/Free Full Text].
|
| 14.
|
Matsushita, S.,
M. Robert-Guroff,
J. Rusche,
A. Koito,
T. Hattori,
H. Hoshino,
K. Javaherian,
K. Takatsuki, and S. Putney.
1988.
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.
J. Virol.
62:2107-2114[Abstract/Free Full Text].
|
| 15.
|
Miller, M. A.,
T. A. Mietzner,
M. W. Cloyd,
W. G. Robey, and R. C. Montelaro.
1993.
Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein.
AIDS Res. Hum. Retroviruses
9:1057-1066[Medline].
|
| 16.
|
Mori, T.,
K. Ando,
K. Tanaka,
Y. Ikeda, and Y. Koga.
1997.
Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus.
Blood
89:3565-3573[Abstract/Free Full Text].
|
| 17.
|
Moroi, Y.,
Y. Koga,
K. Nakamura,
M. Ohtsu,
G. Kimura, and K. Nomoto.
1991.
Accumulation of p60lck in HTLV-1-transformed T cell lines detected by an anti-Lck monoclonal antibody, MOL171.
Jpn. J. Cancer Res.
82:909-915[Medline].
|
| 18.
|
Neylon, C. B.,
J. Hoyland,
W. T. Mason, and R. F. Irvine.
1990.
Spatial dynamics of intracellular calcium in agonist-stimulated vascular smooth muscle cells.
Am. J. Physiol.
259:C675-C686[Abstract/Free Full Text].
|
| 19.
|
Nicotera, P.,
D. J. McConkey,
D. P. Jones, and S. Orrenius.
1989.
ATP stimulates Ca2+ uptake and increases the free Ca2+ concentration in isolated rat liver nuclei.
Proc. Natl. Acad. Sci. USA
86:453-457[Abstract/Free Full Text].
|
| 20.
|
Ratner, L.,
W. Haseltine,
R. Patarca,
K. J. Livak,
B. Starcich,
S. F. Josephs,
E. R. Doran,
J. A. Rafalski,
E. A. Whitehorn,
K. Baumeister,
L. Ivanoff,
S. R. Petteway, Jr.,
M. L. Pearson,
J. A. Lautenberger,
T. S. Papas,
J. Ghrayeb,
N. T. Chang,
R. C. Gallo, and F. Wong-Staal.
1985.
Complete nucleotide sequence of the AIDS virus, HTLV-III.
Nature (London)
313:277-284[Medline].
|
| 21.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed., p. 15.74-15.79.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 22.
|
Sasaki, M.,
J. Uchiyama,
H. Ishikawa,
S. Matsushita,
G. Kimura,
K. Nomoto, and Y. Koga.
1996.
Induction of apoptosis by calmodulin-dependent intracellular Ca2+ elevation in CD4+ cells expressing gp160 of HIV.
Virology
224:18-24[Medline].
|
| 23.
|
Schiefer, S.
1986.
Calmodulin, p. 317-331.
In
H. U. Bergmeyer, J. Bergmeyer, and M. Grable (ed.), Methods of enzymatic analysis, vol. 9. VCH Publishers, Deerfield Beach, Fla.
|
| 24.
|
Shen, Y., and T. E. Shenk.
1995.
Viruses and apoptosis.
Curr. Opin. Genet. Dev.
5:105-111[Medline].
|
| 25.
|
Srinivas, S. K.,
R. V. Srinivas,
G. M. Anantharamaiah, R.,
W. Compans, and J. P. Segrest.
1993.
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
J. Biol. Chem.
268:22895-22899[Abstract/Free Full Text].
|
J Virol, August 1998, p. 6574-6580, Vol. 72, No. 8
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Taylor, B. M., Foulke, J. S., Flinko, R., Heredia, A., DeVico, A., Reitz, M.
(2008). An Alteration of Human Immunodeficiency Virus gp41 Leads to Reduced CCR5 Dependence and CD4 Independence. J. Virol.
82: 5460-5471
[Abstract]
[Full Text]
-
Wyss, S., Dimitrov, A. S., Baribaud, F., Edwards, T. G., Blumenthal, R., Hoxie, J. A.
(2005). Regulation of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Fusion by a Membrane-Interactive Domain in the gp41 Cytoplasmic Tail. J. Virol.
79: 12231-12241
[Abstract]
[Full Text]
-
Ye, L., Bu, Z., Vzorov, A., Taylor, D., Compans, R. W., Yang, C.
(2004). Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain. J. Virol.
78: 13409-13419
[Abstract]
[Full Text]
-
Kalia, V., Sarkar, S., Gupta, P., Montelaro, R. C.
(2003). Rational Site-Directed Mutations of the LLP-1 and LLP-2 Lentivirus Lytic Peptide Domains in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 Indicate Common Functions in Cell-Cell Fusion but Distinct Roles in Virion Envelope Incorporation. J. Virol.
77: 3634-3646
[Abstract]
[Full Text]
-
Evans, D. T., Tillman, K. C., Desrosiers, R. C.
(2002). Envelope Glycoprotein Cytoplasmic Domains from Diverse Lentiviruses Interact with the Prenylated Rab Acceptor. J. Virol.
76: 327-337
[Abstract]
[Full Text]
-
Sasaki, M., Miyazaki, K., Koga, Y., Kimura, G., Nomoto, K., Yoshida, H.
(2002). Calcineurin-Dependent Mitochondrial Disturbances in Calcium-Induced Apoptosis of Human Immunodeficiency Virus gp160-Expressing CD4+ Cells. J. Virol.
76: 416-420
[Abstract]
[Full Text]
-
Piller, S. C., Dubay, J. W., Derdeyn, C. A., Hunter, E.
(2000). Mutational Analysis of Conserved Domains within the Cytoplasmic Tail of gp41 from Human Immunodeficiency Virus Type 1: Effects on Glycoprotein Incorporation and Infectivity. J. Virol.
74: 11717-11723
[Abstract]
[Full Text]
-
Akari, H., Fukumori, T., Adachi, A.
(2000). Cell-Dependent Requirement of Human Immunodeficiency Virus Type 1 gp41 Cytoplasmic Tail for Env Incorporation into Virions. J. Virol.
74: 4891-4893
[Abstract]
[Full Text]
-
Micoli, K. J., Pan, G., Wu, Y., Williams, J. P., Cook, W. J., McDonald, J. M.
(2000). Requirement of Calmodulin Binding by HIV-1 gp160 for Enhanced FAS-mediated Apoptosis. J. Biol. Chem.
275: 1233-1240
[Abstract]
[Full Text]